Gut microbes may determine patients' response to a drug that delays onset of type 1 diabetes - Medical Xpress
medicalxpress.comSubmitted by medicalxpress5525 in health
The microbiome offers a motherlode of data about health and disease, and new findings suggest that antibodies to gut microbes can determine how well patients respond to a new monoclonal antibody drug that delays the onset of type 1 diabetes.